Study of Perioperative Chemotherapy Combined With Tislelizumab and Trastuzumab in the Treatment of GC/EGC
Clinical trial NCT04819971 · UNKNOWN
Trial details
- NCT number
- NCT04819971
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2025-12-31
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.